Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

128 results about "Ultrasonic cardiography" patented technology

System for transmitting video streams using a plurality of levels of quality over a data network to a remote receiver

A method of and apparatus for transmitting video images allows a viewer to receive at a receiving display device, all or a selected portion of a video stream of frames, in a storage-efficient format from a transmitting device and view the received video stream of frames before the transmission is complete. The video system also allows a viewer to receive at the receiving device, all or a selected portion of a video stream of frames, in a high-resolution format, by marking sections of interest within the received stream of frames in the storage-efficient format and requesting enhancement of those marked sections of interest. This apparatus preferably includes a source device, a transmitting device and at least one receiving device. Preferably, the transmitting device and the receiving device communicate over a network such as the Internet Protocol network. Alternatively, the transmitting device and the receiving device communicate over any appropriate data network. The transmitting device transmits the video images to the receiving device for display and storage at the receiving device. The receiving device is also capable of communicating with the transmitting device while simultaneously receiving video images. The source device is preferably a medical test device such as an ultrasound, a sonogram, an echocardiogram, and the like. Alternatively, the source device can be any video capture or storage device capable of sourcing a stream of video frames.
Owner:ZIN STAI PTE IN

System for transmitting a video stream over a computer network to a remote receiver

A method of and system for transmitting video images preferably allows a specially trained individual to remotely supervise, instruct, and observe administration of medical tests conducted at remote locations. This system preferably includes a source device, a transmitting device, and at least one remote receiving device. The transmitting device, and the remote receiving device communicate over a network such as any appropriate data network. The transmitting device transmits the video images to the remote receiving device either for live display from the source device or for pre-recorded display from a video recorder device. The remote receiving device is also capable of communicating with the transmitting device while simultaneously receiving video images to provide remote control. The source device is preferably a medical test device such as an ultrasound, a sonogram, an echocardiogram, an angioplastigram, and the like. The transmitting device captures the video images in real-time from the source device and compresses these video images utilizing a compression method prior to transmitting data representing the video images to the remote receiving device. The compressor and compression method preferably utilize data structures comprising line number data structures and the repeat data structures. Remote users utilizing the remote receiving devices are capable of viewing a live stream of video and remotely controlling a number of parameters relating to the source device and the transmitting device. Such parameters include compression method, image quality, storage of the video images on the transmitting device, manipulating and controlling the source device, and the like.
Owner:SECURE CAM LLC

Method and apparatus for determining an efficacious atrioventricular delay interval

ActiveUS20050149137A1Minimize uncoordinated cardiac motionMaximize the benefitsHeart stimulatorsDemographic dataDemographics
Determining an optimal atrioventricular interval is of interest for proper delivery of cardiac resynchronization therapy. Although device optimization is gradually and more frequently being performed through a referral process with which the patient undergoes an echocardiographic optimization, the decision of whether to optimize or not is still generally reserved for the implanting physician. Recent abstracts have suggested a formulaic approach for setting A-V interval based on intrinsic electrical sensing, that may possess considerable appeal to clinicians versus a patient average nominal A-V setting of 100 ms. The present invention presents a methods of setting nominal device settings based on entering patient cardiac demographics to determine what A-V setting may be appropriate. The data is based on retrospective analysis of the MIRACLE trial to determine what major factors determined baseline A-V settings.
Owner:MEDTRONIC INC

Microembolic signals detection during cordiopulmonary bypass

InactiveUS20110054322A1Ultrasonic/sonic/infrasonic diagnosticsCatheterSystemic embolismCardiac echo
In a method of detecting microemboli in a patient, an echography probe is applied to a selected location of the patient. An ultrasonic signal is sensed with the echocardiography probe. The ultrasonic signal is processed with a processor to determine a systemic embolic load in the selected location. A representation of a systemic embolic load indicated by the ultrasonic signal is presented to a user.
Owner:ZANATTA PAOLO

Transesophageal ultrasound using a narrow probe

Transesophageal echocardiography is implemented using a miniature transversely oriented transducer that is preferably small enough to fit in a 7.5 mm diameter probe, and most preferably small enough to fit in a 5 mm diameter probe. Signal processing techniques improve the depth of penetration to the point where the complete trans-gastric short axis view of the left ventricle can be obtained, despite the fact that the transducer is so small. The reduced diameter of the probe (as compared to prior art probes) reduces risks to patients, reduces or eliminates the need for anesthesia, and permits long term direct-visualization monitoring of patients' cardiac function.
Owner:IMACOR INC

Echocardiographic ventricle segmentation method and device based on deep learning and deformation model

The invention relates to an echocardiographic ventricle segmentation method and device based on deep learning and a deformation model, and aims at ironing out a defect that a conventional manual boundary marking method exerts a big negative impact on the calculation of the related indexes of a ventricle because the conventional manual boundary marking method usually consumes a large amount of manpower and material resources and the marking results of different persons are different. The method comprises the steps: carrying out the training of a ventricle coarse segmentation model through manually marked training data, and obtaining a coarse segmentation training result; calculating the central point of the coarse segmentation training result on each section, carrying out the fitting of oneline through all central points, and calculating the mean value of the distances between the central points in a direction perpendicular to the line and an outer edge of the coarse segmentation training result as the radius; carrying out the resampling according to the calculated central points and the radius, and reconstructing a three-dimensional initialization model based on a sampling result;and carrying out the fine segmentation of the ventricle coarse segmentation result through the deformation model. The method is suitable for the ventricle image processing.
Owner:HARBIN INST OF TECH

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto

The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g., kidney damage or failure, heart valve problems, heart rhythm problems, and/or liver damage); heart failure due to left ventricular dysfunction; heart failure with normal ejection fraction; cardiovascular mortality following myocardial infarction; cardiovascular mortality in patients with left ventricular failure or left ventricular dysfunction; left ventricular failure; left ventricular dysfunction; class II heart failure using the New York Heart Association (NYHA) classification system; class III heart failure using the New York Heart Association (NYHA) classification system; class IV heart failure using the New York Heart Association (NYHA) classification system; LVEF<40% by radionuclide ventriculography; LVEF≤35% by echocardiography or ventricular contrast angiography; and conditions related thereto.
Owner:ARENA PHARMA

Mitral valve opening area detection method, system and device based on artificial intelligence

The invention discloses a mitral valve opening area detection method, system and device based on artificial intelligence. The method comprises the steps that a two-dimensional section video reflectinga mitral valve structure in an ultrasonic cardiogram of a detection object is acquired; inputting the two-dimensional section video into a trained deep learning classification model, and obtaining aprediction value of the two-dimensional section video containing mitral valve stenosis image features; if the prediction value meets a preset condition, inputting the heart tip four-cavity heart mitral valve continuous Doppler frequency spectrum section image of the detection object into an image segmentation network model, and obtaining a frequency spectrum oscillogram corresponding to the section image; and predicting the mitral valve opening area according to the frequency spectrum oscillogram. According to the method, the system and the equipment, the accuracy and the consistency of ultrasonic detection are greatly improved.
Owner:GENERAL HOSPITAL OF PLA

Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device

Artificial intelligence (AI) recognition of echocardiogram (echo) images by a mobile ultrasound device comprises receiving a plurality of the echo images captured by the ultrasound device, the ultrasound device including a display and a user interface (UI) that displays the echo images to a user, the echo images comprising 2D images and Doppler modality images of a heart. One or more neural networks process the echo images to automatically classify the echo images by view type. The view type of the echo images is simultaneously displayed in the UI of the ultrasound device along with the echo images. A report is generated showing the calculated measurements of features in the echo images. The report showing the calculated measurements is displayed on a display device.
Owner:EKO AI PTE LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products